首页> 外文期刊>Acta medica Iranica. >COMPARISON OF INSURE METHOD WITH CONVENTIONAL MECHANICAL VENTILATION AFTER SURFACTANT ADMINISTRATION IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME: THERAPEUTIC CHALLENGE
【24h】

COMPARISON OF INSURE METHOD WITH CONVENTIONAL MECHANICAL VENTILATION AFTER SURFACTANT ADMINISTRATION IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME: THERAPEUTIC CHALLENGE

机译:呼吸窘迫综合征早产儿经表面活性剂管理后与常规机械通气的比较:治疗上的挑战

获取原文
           

摘要

Administration of endotracheal surfactant is potentially the main treatment for neonates suffering from RDS (Respiratory Distress Syndrome), which is followed by mechanical ventilation. Late and severe complications may develop as a consequence of using mechanical ventilation. In this study, conventional methods for treatment of RDS are compared with surfactant administration, use of mechanical ventilation for a brief period and NCPAP (Nasal Continuous Positive Airway Pressure), (INSURE method ((Intubation, Surfactant administration and extubation)). A randomized clinical trial study was performed, including all newborn infants with diagnosed RDS and a gestational age of 35 weeks or less, who were admitted in NICU of Valiasr hospital. The patients were then divided randomly into two CMV (Conventional Mechanical Ventilation) and INSURE groups. Surfactant administration and consequent long-term mechanical ventilation were done in the first group (CMV group). In the second group (INSURE group), surfactant was administered followed by a short-term period of mechanical ventilation. The infants were then extubated, and NCPAP was embedded. The comparison included crucial duration of mechanical ventilation and oxygen therapy, IVH (Intraventricular Hemorrhage), PDA (Patent Ductus Arteriosus), air-leak syndromes, BPD (Broncho-Pulmonary Dysplasia) and mortality rate. The need for mechanical ventilation in 5th day of admission was 43% decreased (P=0.005) in INSURE group in comparison to CMV group. A decline (P=0.01) in the incidence of IVH and PDA was also achieved. Pneumothorax, chronic pulmonary disease and mortality rates, were not significantly different among two groups. (P=0.25, P=0.14, P=0.25, respectively). This study indicated that INSURE method in the treatment of RDS decreases the need for mechanical ventilation and oxygen-therapy in preterm neonates. Moreover, relevant complications as IVH and PDA were observed to be reduced. Thus, it seems rationale to perform this method as the initial treatment for neonates with mild to moderate RDS.
机译:气管内表面活性剂的给药可能是患有RDS(呼吸窘迫综合征)的新生儿的主要治疗方法,然后进行机械通气。使用机械通气可能会导致晚期和严重的并发症。在这项研究中,将RDS的常规治疗方法与表面活性剂管理,短期使用机械通气和NCPAP(鼻持续气道正压通气)进行比较(INSURE方法((插管,表面活性剂给药和拔管))。进行了临床试验研究,包括所有在Valiasr医院的NICU入院的,诊断为RDS且胎龄在35周以下的新生儿,然后将患者随机分为两个CMV(常规机械通气)组和INSURE组。在第一组(CMV组)中进行了表面活性剂的给药并随后进行了长期的机械通气;在第二组(INSURE组)中进行了表面活性剂的治疗,随后进行了短期机械通气,然后将婴儿拔管,嵌入了NCPAP,比较包括机械通气和氧气治疗的关键持续时间,IVH(脑室内出血),PDA(动脉导管未闭,气漏综合征,BPD(支气管-肺发育不良)和死亡率。与CMV组相比,INSURE组入院第5天的机械通气需求减少了43%(P = 0.005)。 IVH和PDA的发生率也降低了(P = 0.01)。两组之间的气胸,慢性肺疾病和死亡率没有显着差异。 (分别为P = 0.25,P = 0.14,P = 0.25)。这项研究表明,INSURE治疗RDS可以减少早产儿机械通气和氧气治疗的需要。此外,观察到IVH和PDA的相关并发症减少了。因此,将这种方法作为具有轻度至中度RDS的新生儿的初始治疗似乎是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号